199 related articles for article (PubMed ID: 18725544)
1. Contribution of down-regulation of intestinal and hepatic cytochrome P450 3A to increased absorption of cyclosporine A in a rat nephrosis model.
Fujita T; Yasuda S; Kamata Y; Fujita K; Ohtani Y; Kumagai Y; Majima M
J Pharmacol Exp Ther; 2008 Nov; 327(2):592-9. PubMed ID: 18725544
[TBL] [Abstract][Full Text] [Related]
2. An antioxidant Trolox restores decreased oral absorption of cyclosporine A after liver ischemia-reperfusion through distinct mechanisms between CYP3A and P-glycoprotein in the small intestine.
Ikemura K; Inoue K; Mizutani H; Oka H; Iwamoto T; Okuda M
Eur J Pharmacol; 2012 Sep; 690(1-3):192-201. PubMed ID: 22749977
[TBL] [Abstract][Full Text] [Related]
3. Decreased oral absorption of cyclosporine A after liver ischemia-reperfusion injury in rats: the contribution of CYP3A and P-glycoprotein to the first-pass metabolism in intestinal epithelial cells.
Ikemura K; Urano K; Matsuda H; Mizutani H; Iwamoto T; Okuda M
J Pharmacol Exp Ther; 2009 Jan; 328(1):249-55. PubMed ID: 18842703
[TBL] [Abstract][Full Text] [Related]
4. Impact of MDR1 and CYP3A5 on the oral clearance of tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patients.
Fukudo M; Yano I; Yoshimura A; Masuda S; Uesugi M; Hosohata K; Katsura T; Ogura Y; Oike F; Takada Y; Uemoto S; Inui K
Pharmacogenet Genomics; 2008 May; 18(5):413-23. PubMed ID: 18408564
[TBL] [Abstract][Full Text] [Related]
5. Selective induction of intestinal CYP3A23 by 1alpha,25-dihydroxyvitamin D3 in rats.
Xu Y; Iwanaga K; Zhou C; Cheesman MJ; Farin F; Thummel KE
Biochem Pharmacol; 2006 Jul; 72(3):385-92. PubMed ID: 16769037
[TBL] [Abstract][Full Text] [Related]
6. Effects of liver fibrosis on verapamil pharmacokinetics in rats.
Chen M; Xu D; Hu XL; Wang H
Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):287-94. PubMed ID: 17973928
[TBL] [Abstract][Full Text] [Related]
7. Comparison of mouse and rat cytochrome P450-mediated metabolism in liver and intestine.
Martignoni M; Groothuis G; de Kanter R
Drug Metab Dispos; 2006 Jun; 34(6):1047-54. PubMed ID: 16565172
[TBL] [Abstract][Full Text] [Related]
8. Demonstration of docosahexaenoic acid as a bioavailability enhancer for CYP3A substrates: in vitro and in vivo evidence using cyclosporin in rats.
Hirunpanich V; Katagi J; Sethabouppha B; Sato H
Drug Metab Dispos; 2006 Feb; 34(2):305-10. PubMed ID: 16299163
[TBL] [Abstract][Full Text] [Related]
9. Impact of curcumin-induced changes in P-glycoprotein and CYP3A expression on the pharmacokinetics of peroral celiprolol and midazolam in rats.
Zhang W; Tan TM; Lim LY
Drug Metab Dispos; 2007 Jan; 35(1):110-5. PubMed ID: 17050652
[TBL] [Abstract][Full Text] [Related]
10. Altered expression of NDST-1 messenger RNA in puromycin aminonucleoside nephrosis.
Nakayama K; Natori Y; Sato T; Kimura T; Sugiura A; Sato H; Saito T; Ito S; Natori Y
J Lab Clin Med; 2004 Feb; 143(2):106-14. PubMed ID: 14966466
[TBL] [Abstract][Full Text] [Related]
11. Evidence for cytochrome P450 3A expression and catalytic activity in rat blood lymphocytes.
Dey A; Yadav S; Dhawan A; Seth PK; Parmar D
Life Sci; 2006 Sep; 79(18):1729-35. PubMed ID: 16844145
[TBL] [Abstract][Full Text] [Related]
12. In vivo induction of hepatic p-glycoprotein by cyclosporine in the rat.
Bai S; Liu J; Lu SK; Brunner LJ
Res Commun Mol Pathol Pharmacol; 2001 Jul; 109(1-2):103-14. PubMed ID: 11458978
[TBL] [Abstract][Full Text] [Related]
13. Hydroxyitraconazole, formed during intestinal first-pass metabolism of itraconazole, controls the time course of hepatic CYP3A inhibition and the bioavailability of itraconazole in rats.
Quinney SK; Galinsky RE; Jiyamapa-Serna VA; Chen Y; Hamman MA; Hall SD; Kimura RE
Drug Metab Dispos; 2008 Jun; 36(6):1097-101. PubMed ID: 18339815
[TBL] [Abstract][Full Text] [Related]
14. Dextran sulfate sodium-induced colitis and ginseng intervention altered oral pharmacokinetics of cyclosporine A in rats.
Yang Y; Hu N; Gao XJ; Li T; Yan ZX; Wang PP; Wei B; Li S; Zhang ZJ; Li SL; Yan R
J Ethnopharmacol; 2021 Jan; 265():113251. PubMed ID: 32810615
[TBL] [Abstract][Full Text] [Related]
15. Age-related differences in CYP3A expression and activity in the rat liver, intestine, and kidney.
Warrington JS; Greenblatt DJ; von Moltke LL
J Pharmacol Exp Ther; 2004 May; 309(2):720-9. PubMed ID: 14742746
[TBL] [Abstract][Full Text] [Related]
16. Faster clearance of omeprazole in rats with acute renal failure induced by uranyl nitrate: contribution of increased expression of hepatic cytochrome P450 (CYP) 3A1 and intestinal CYP1A and 3A subfamilies.
Lee DY; Jung YS; Shin HS; Lee I; Kim YC; Lee MG
J Pharm Pharmacol; 2008 Jul; 60(7):843-51. PubMed ID: 18549670
[TBL] [Abstract][Full Text] [Related]
17. Influence of intravenous methylprednisolone pulse treatment on the disposition of ciclosporin and hepatic CYP3A activity in rats.
Konishi H; Sumi M; Shibata N; Takada K; Minouchi T; Yamaji A
J Pharm Pharmacol; 2004 Apr; 56(4):477-83. PubMed ID: 15099443
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms in CYP3A5 and MDR1 genes and their correlations with plasma levels of tacrolimus and cyclosporine in renal transplant recipients.
Mendes J; Martinho A; Simoes O; Mota A; Breitenfeld L; Pais L
Transplant Proc; 2009 Apr; 41(3):840-2. PubMed ID: 19376366
[TBL] [Abstract][Full Text] [Related]
19. Role of uroguanylin, a Peptide with natriuretic activity, in rats with experimental nephrotic syndrome.
Kikuchi M; Fujimoto S; Fukae H; Kinoshita H; Kita T; Nakazato M; Eto T
J Am Soc Nephrol; 2005 Feb; 16(2):392-7. PubMed ID: 15590761
[TBL] [Abstract][Full Text] [Related]
20. P-glycoprotein and an unstirred water layer barring digoxin absorption in the vascularly perfused rat small intestine preparation: induction studies with pregnenolone-16alpha-carbonitrile.
Liu S; Tam D; Chen X; Pang KS
Drug Metab Dispos; 2006 Sep; 34(9):1468-79. PubMed ID: 16751264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]